Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone

NCT01332370 · clinicaltrials.gov ↗

COMPLETED

Status

5391

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone + Metformin
DRUG: Sitagliptin + Metformin

Sponsor

GlaxoSmithKline